Clinical Trial Update: Sublingual Buprenorphine Treatment for Neonatal Abstinence Syndrome - Pilot Study [Phase 1, Phase 2]

View source ↗

Summary

This document reports a pilot Phase 1/2 clinical trial evaluating sublingual buprenorphine for neonatal abstinence syndrome; the current status is unknown.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Neonatal Abstinence Syndrome

Drugs mentioned

• Sublingual Buprenorphine (buprenorphine)

Snippet

Sponsor: Gauda, Estelle B., M.D. | Conditions: Drug; Withdrawal Symptoms, Neonatal, Withdrawal | Phase 1, Phase 2 | Status: UNKNOWN